NGMDF (NuGen Medical Devices) Forward PE Ratio: 0.00 (As of Jul. 05, 2026)


What is NuGen Medical Devices Forward PE Ratio?

NuGen Medical Devices NGMDF Forward PE Ratio is 0.00 as of Jul. 05, 2026. The stock has 7 warning signs investors should review. Among 392 Medical Devices & Instruments companies, NuGen Medical Devices ranks worse than 255101.79% on this metric.

NuGen Medical Devices's Forward PE Ratio for today is 0.00.

NuGen Medical Devices's PE Ratio without NRI for today is 0.00.

NuGen Medical Devices's PE Ratio (TTM) for today is 0.00.


NuGen Medical Devices  (OTCPK:NGMDF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


NuGen Medical Devices Forward PE Ratio Related Terms


NuGen Medical Devices Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for NuGen Medical Devices's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NuGen Medical Devices Forward PE Ratio Chart

NuGen Medical Devices Annual Data
Trend
Forward PE Ratio

NuGen Medical Devices Quarterly Data
Forward PE Ratio

NGMDF vs ABT, SYK, MDT: Forward PE Ratio Comparison

For the Medical Devices subindustry, NuGen Medical Devices's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NuGen Medical Devices Forward PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NuGen Medical Devices's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where NuGen Medical Devices's Forward PE Ratio falls into.



NuGen Medical Devices Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
NuGen Medical Devices (NGMDF) has a Forward PE Ratio of 0.00 as of Jul. 05, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on NuGen Medical Devices and its competitors. According to the industry distribution chart, NuGen Medical Devices ranks #999999 out of 392 companies in the Medical Devices & Instruments industry.
Is NuGen Medical Devices' Forward PE Ratio too high?
NuGen Medical Devices' current Forward PE Ratio is 0.00. Based on the distribution chart, NuGen Medical Devices ranks #999999 out of 392 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does NuGen Medical Devices' Forward PE Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, NuGen Medical Devices ranks #999999 out of 392 companies for Forward PE Ratio. This places NuGen Medical Devices in the lower half of its industry. The industry median Forward PE Ratio is 19.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 19.31, based on 392 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on NuGen Medical Devices and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 19.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NuGen Medical Devices's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NuGen Medical Devices stock overvalued right now?
Based on GuruFocus' analysis, NuGen Medical Devices (NGMDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.02, compared to a current price of $0.02 — trading 21.8% below its estimated fair value. The current Forward PE Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For NuGen Medical Devices (NGMDF), the current Forward PE Ratio is 0.00 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NuGen Medical Devices Business Description

Other Exchanges 79O:GermanyNGMD:Canada
Address 18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needle injector devices. Geographically, the company generates revenue from Europe, followed by Asia, and other.